Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058849 · ClinicalTrials.gov registry record · Phase 2
Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
A Phase 2 study, sponsored by David Travis Thomas.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT02058849 is a Phase 2 study that has completed, run by David Travis Thomas. The registered enrollment target is 13 participants.
The verdict
NCT02058849, a Phase 2 study, has completed, sponsored by David Travis Thomas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The objective of the current proposal is to determine if concentrated beet root could improve medical treatment compliance as defined by completion of radiotherapy and 3 cycles of chemoradiation without dose reduction, preserve fat-free mass, and strength while reducing mucositis. The investigators central hypothesis is that dietary nitrate supplementation in head and neck cancer patients receiving aggressive medical care will improve compliance with medical treatment by attenuating the loss of muscle mass and strength and reducing symptoms (mucositis) associated with treatment compared to patients receiving standard care with placebo.
Interventions
- OTHER Placebo
- DRUG Beetroot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-05-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058849
The ClinicalTrials.gov registry entry for NCT02058849 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Travis Thomas, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02058849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02058849 about?
NCT02058849 is a clinical study titled "Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck". The objective of the current proposal is to determine if concentrated beet root could improve medical treatment compliance as defined by completion of radiotherapy and 3 cycles of chemoradiation without dose reduction, preserve fat-free mass, and strength while reducing mucositis. The investigators ...
What is the current status of trial NCT02058849?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2014-12. Estimated completion is 2018-05-01.
What interventions are being tested in trial NCT02058849?
The interventions under investigation include: Placebo (OTHER), Beetroot (DRUG).
Who is sponsoring clinical trial NCT02058849?
This trial is sponsored by David Travis Thomas, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.